Australian and New Zealand radiation oncologists with an interest in uro-oncology were invited to participate in a pattern-of-practice survey dealing with the management of intact high-risk prostate cancer.
Responses from 46 practitioners (representing 73% of all potential respondents) revealed that high-dose radiation therapy is the standard of care. However, there is variability in practice with regard to the methods used to achieve dose escalation, the use of whole-pelvic radiation therapy and the optimal duration of androgen deprivation therapy employed. A review of the literature outlining the current body of knowledge and the planned and ongoing studies in intact high-risk prostate cancer is presented.
Written by:
Lehman M, Hayden AJ, Martin JM, Christie D, Kneebone AB, Sidhom M, Skala M, Tai KH. Are you the author?
Radiation Oncology Department, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
Reference: J Med Imaging Radiat Oncol. 2013 Dec 5. Epub ahead of print.
doi: 10.1111/1754-9485.12142
PubMed Abstract
PMID: 24304822
UroToday.com Prostate Cancer Section
